Author: Arvin Arvin

  • Report: M&A Update | Recruitment

    Report: M&A Update | Recruitment
    Categories:

    Report: M&A Update | Recruitment We share here our latest report into the Human Capital Sector, M&A Update | Recruitment. Mark Kingston, Director of Human Capital M&A at Cavendish discussed these findings in a recent podcast (listen to the podcast here). We are now delighted to be able to share this report in full, which looks…

    Read more

  • An Open Letter to the Chancellor

    An Open Letter to the Chancellor
    Categories:

    An Open Letter to the Chancellor Dear Chancellor of the Exchequer, We recognise that any income we draw from our business should be taxed with income tax but we believe that the risk we took in starting and investing in a UK business, providing jobs and prosperity for others, should be recognised by an appropriate…

    Read more

  • Podcast: Are we all impact investors now?

    Podcast: Are we all impact investors now?
    Categories:

    Podcast: Are we all impact investors now? In our latest podcast we hear from the voices of UK private equity on the rising importance of ESG and the influence on their portfolios. While it is certainly not news that ESG – environmental, social and governance commitments – is an important driver of growth amongst our…

    Read more

  • How scale-ups access later stage growth capital

    How scale-ups access later stage growth capital
    Categories:

    How scale-ups access later stage growth capital The problem with being a scale-up is right there in the name – scaling. It’s hard. Put simply, when your revenue is in the low millions it’s easier to double your sales and impress investors. As you make more money and grow, so do those challenges scale with…

    Read more

  • Funding, Floating and Selling Your Business Post-COVID

    Funding, Floating and Selling Your Business Post-COVID
    Categories:

    Funding, Floating and Selling Your Business Post-COVID Lord Leigh of Hurley: After the unprecedented disruption caused by COVID-19, it is critical that businesses are assisted in every way possible to ensure the UK’s economic recovery over the next few years. But at the moment, many entrepreneurs are uncertain about the direction in which they should…

    Read more

  • With CGT changes likely, let’s review the facts

    With CGT changes likely, let’s review the facts
    Categories:

    With CGT changes likely, let’s review the facts Lord Leigh of Hurley, Deputy Chairman of finnCap Group & Senior Partner for Cavendish Corporate Finance LLP: With the UK Government’s Office of Tax Simplification (OTS) review of Capital Gains Tax (CGT) underway, it is worth considering that – whilst the precise outcome is unknown – Ministers…

    Read more

  • Deal or No Deal: What factors are driving a fractured return for M&A?

    Deal or No Deal: What factors are driving a fractured return for M&A?
    Categories: , , ,

    Deal or No Deal: What factors are driving a fractured return for M&A? New Cavendish Corporate Finance Partner Karri Vuori  talked to CNBC’s Squawk Box Europe about the turbulence in the deal-making market and the shifting trends that have occurred during the first three quarters of a pandemic ravaged year. An ‘epic disaster for M&A’…

    Read more

  • Private equity: Bolt-on wonderers

    Private equity: Bolt-on wonderers
    Categories:

    Private equity: Bolt-on wonderers COVID and the ensuing economic downturn have pressed on accelerator pedals far and wide; in the world of private equity this has manifested in a penchant for bolt-on acquisitions. Funds are keen to deploy their record levels of dry powder. Now is the time for focused bolt-on acquisitions to take advantage…

    Read more

  • Why Legal Tech is making a case for M&A

    Why Legal Tech is making a case for M&A
    Categories:

    Why Legal Tech is making a case for M&A The COVID-19 pandemic has accelerated the digital transformation of many a sector and the legal profession is no different. In fact, the rapidly burgeoning industry of ‘Legal Tech’ has been quietly and fundamentally changing the face of the law for the past few years. And it’s…

    Read more

  • Cell & Gene Therapy: The future of medicine attracts major M&A activity

    Cell & Gene Therapy: The future of medicine attracts major M&A activity
    Categories:

    Cell & Gene Therapy: The future of medicine attracts major M&A activity The Life Sciences sector has recently had the spotlight shining upon it, as a result of the global COVID-19 pandemic, and we have seen extensive investment and redeployment and refocusing of resources seeking appropriate diagnostics, treatments and vaccines. But while all this is…

    Read more